28608
中文   |   English 手机浏览
Yong Liu Professor Cancer Biotherapy Institute and National Joint Engineering Laboratory for Cancer Biotherapy
Research Interest (1) From metabolomics to proteomics: retrograde regulation of cancer signaling by onco-metabolites； (2) Redox balance conferred by mitochondria in tumorigenesis, metastasis, and drug resistance; (3) Drug screening targeting TME to develop novel immuno-activating therapeutical approaches.
Research More >
Retrograde regulation of cancer signaling by lipid-based metabolites through PTM Redox balance in cancer metastasis and drug-resistance Drug discovery by targeting to RPs-MDM2-p53 pathway
News More >
Events More >
Useful Links
You are the 28608 visitor